193 related articles for article (PubMed ID: 30705367)
1. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
[TBL] [Abstract][Full Text] [Related]
2. Methylation of ERβ 5'-untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer.
Xu LW; Gou X; Yang JY; Jiang R; Jiang X; Chen GG; Liu ZM
FASEB J; 2021 Apr; 35(4):e21516. PubMed ID: 33710697
[TBL] [Abstract][Full Text] [Related]
3. PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.
Li J; Zhuang Q; Lan X; Zeng G; Jiang X; Huang Z
IUBMB Life; 2013 Dec; 65(12):1017-25. PubMed ID: 24376209
[TBL] [Abstract][Full Text] [Related]
4. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
5. PES1 promotes breast cancer by differentially regulating ERα and ERβ.
Cheng L; Li J; Han Y; Lin J; Niu C; Zhou Z; Yuan B; Huang K; Li J; Jiang K; Zhang H; Ding L; Xu X; Ye Q
J Clin Invest; 2012 Aug; 122(8):2857-70. PubMed ID: 22820289
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.
Dong WW; Li J; Li J; Zhang P; Wang ZH; Sun W; Zhang H
Int J Exp Pathol; 2018 Feb; 99(1):15-21. PubMed ID: 29655286
[TBL] [Abstract][Full Text] [Related]
7. Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.
Dai YJ; Qiu YB; Jiang R; Xu M; Zhao L; Chen GG; Liu ZM
Sci Rep; 2017 Sep; 7(1):12279. PubMed ID: 28947799
[TBL] [Abstract][Full Text] [Related]
8. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
11. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
13. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
15. Decreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162942
[TBL] [Abstract][Full Text] [Related]
16. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
Ding Z; Ke R; Zhang Y; Fan Y; Fan J
Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275
[TBL] [Abstract][Full Text] [Related]
17. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
[TBL] [Abstract][Full Text] [Related]
18. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
19. [Effects of UHRF1 on Estrogen Receptor and Proliferation, Invasion and Migration of BCPAP Cells in Thyroid Papillary Carcinoma].
Xu LW; Zhang LY; Gou X; Qiu YB; Liu ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):325-330. PubMed ID: 32543137
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
